Testing effectiveness (Phase 2)Ended earlyNCT04415073
What this trial is testing
Evaluate Axatilimab for Hospitalized Participants With Respiratory Involvement Secondary to COVID-19
Who this might be right for
CoronavirusCOVIDARDS+2 more
Syndax Pharmaceuticals 1